U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT04260347) titled 'SITS-IVT in Patients >80 Years' on Jan. 31.
Brief Summary: A non-interventional post-approval study on Safe Implementation of Treatment in Stroke - International Stroke Thrombolysis Register (SITS-ISTR) existing data of intravenous recombinant tissue plasminogen Activator (rt-PA) (0.9 mg/kg) in acute ischaemic stroke patients over 80 years, treated according to the Summary of Product Characteristics (SmPC) in European countries.
Study Type: Observational
Condition: Ischaemic Stroke
Intervention: Drug: Alteplase
Intravenous injection
Other Name: Actilyse(R)
Recruitment Status: Not Yet Recruiting
Sponsor: Boehringer Ingelheim
...